Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression ; volume:8 ; number:1 ; day:17 ; month:9 ; year:2018 ; pages:1-10 ; date:12.2018
Scientific reports ; 8, Heft 1 (17.9.2018), 1-10, 12.2018
- Urheber
-
Friedman, Gregory K.
- Beteiligte Personen und Organisationen
-
Bernstock, Joshua D.
Chen, Dongquan
Nan, Li
Moore, Blake P.
Kelly, Virginia M.
Youngblood, Samantha L.
Langford, Catherine P.
Han, Xiaosi
Ring, Eric K.
Beierle, Elizabeth A.
Gillespie, G. Yancey
Markert, James M.
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-32353-x
- URN
-
urn:nbn:de:101:1-2018112813393757335667
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Friedman, Gregory K.
- Bernstock, Joshua D.
- Chen, Dongquan
- Nan, Li
- Moore, Blake P.
- Kelly, Virginia M.
- Youngblood, Samantha L.
- Langford, Catherine P.
- Han, Xiaosi
- Ring, Eric K.
- Beierle, Elizabeth A.
- Gillespie, G. Yancey
- Markert, James M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Oncolytic virotherapy of glioblastoma
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Cell type-specific response of colon cancer tumor cell lines to oncolytic HSV-1 virotherapy in hypoxia
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Patient-derived xenografts as preclinical neuroblastoma models
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
Key parameters of measles virus production for oncolytic virotherapy
Oncolytic virotherapy of glioblastoma
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Cell type-specific response of colon cancer tumor cell lines to oncolytic HSV-1 virotherapy in hypoxia
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Patient-derived xenografts as preclinical neuroblastoma models
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
Key parameters of measles virus production for oncolytic virotherapy
Oncolytic virotherapy of glioblastoma
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Cell type-specific response of colon cancer tumor cell lines to oncolytic HSV-1 virotherapy in hypoxia
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Patient-derived xenografts as preclinical neuroblastoma models
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies